These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18191315)

  • 1. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action.
    Bogen KT; Benson JM; Yost GS; Morris JB; Dahl AR; Clewell HJ; Krishnan K; Omiecinski CJ
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S27-36. PubMed ID: 18191315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of whole animal bioassays of the carcinogenic potential of naphthalene.
    North DW; Abdo KM; Benson JM; Dahl AR; Morris JB; Renne R; Witschi H
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S6-14. PubMed ID: 18364246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible genotoxic modes of action for naphthalene.
    Brusick D; Small MS; Cavalieri EL; Chakravarti D; Ding X; Longfellow DG; Nakamura J; Rogan EC; Swenberg JA
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S43-50. PubMed ID: 18194829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid CFD-PBPK model for naphthalene in rat and human with IVIVE for nasal tissue metabolism and cross-species dosimetry.
    Campbell JL; Andersen ME; Clewell HJ
    Inhal Toxicol; 2014 May; 26(6):333-44. PubMed ID: 24666369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of
    Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
    Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
    [No Abstract]   [Full Text] [Related]  

  • 6. A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity.
    Bogdanffy MS; Sarangapani R; Plowchalk DR; Jarabek A; Andersen ME
    Toxicol Sci; 1999 Sep; 51(1):19-35. PubMed ID: 10496674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis-based weight-of-evidence evaluation and risk assessment for naphthalene carcinogenesis.
    Bailey LA; Nascarella MA; Kerper LE; Rhomberg LR
    Crit Rev Toxicol; 2016; 46(1):1-42. PubMed ID: 26202831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure, epidemiology and human cancer incidence of naphthalene.
    Griego FY; Bogen KT; Price PS; Weed DL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S22-6. PubMed ID: 18423820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthalene animal carcinogenicity and human relevancy: overview of industries with naphthalene-containing streams.
    Jeffrey Lewis R
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):131-7. PubMed ID: 22197623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical assessment of the genetic toxicity of naphthalene.
    Brusick D
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S37-42. PubMed ID: 17980943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of naphthalene toward cells from target and non-target organs in vitro.
    Kedderis GL; Shepard KG; Recio L
    Chem Biol Interact; 2014 Feb; 209():85-95. PubMed ID: 24361489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies).
    Natl Toxicol Program Tech Rep Ser; 2000 Dec; (500):1-173. PubMed ID: 11725561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors.
    Frederick CB; Lomax LG; Black KA; Finch L; Scribner HE; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):23-40. PubMed ID: 12217639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating ToxCast™ data into naphthalene human health risk assessment.
    Bailey LA; Rhomberg LR
    Toxicol In Vitro; 2020 Sep; 67():104913. PubMed ID: 32526344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and metabolism of methylnaphthalenes: comparison with naphthalene and 1-nitronaphthalene.
    Lin CY; Wheelock AM; Morin D; Baldwin RM; Lee MG; Taff A; Plopper C; Buckpitt A; Rohde A
    Toxicology; 2009 Jun; 260(1-3):16-27. PubMed ID: 19464565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry.
    Teeguarden JG; Bogdanffy MS; Covington TR; Tan C; Jarabek AM
    Inhal Toxicol; 2008 Feb; 20(4):375-90. PubMed ID: 18302046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
    Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS
    Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
    Quick DJ; Shuler ML
    Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.